Vvus stock split

Vertex Pharmaceuticals Stock Split History

VVUS - Vivus Stock Profile - Barchart.com Company profile for Vivus Inc (VVUS) including business summary, key statistics, ratios, sector. VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. Most Recent Split: The share split recorded and the date on which the split occurred. Vivus (VVUS) Stock Message Board - InvestorsHub Mar 26, 2020 · VIVUS does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in VIVUS' Form 10- K for the year ended December 31, 2006 and periodic reports filed with the Securities and Exchange Commission . VVUS VIVUS, Inc. Stock Quote - FINVIZ.com

VVUS Stock Price, Forecast & News (VIVUS) | MarketBeat

Jul 10, 2018 · VIVUS, Inc. (NASDAQ: VVUS) is headed for the top early on in the trading session this morning and for good reason. The company announced positive preliminary results from a clinical trial. Of cours… VIVUS Inc., VVUS Quick Chart - (NAS) VVUS, VIVUS Inc ... Vivus stock rallies above $5 mark in volatile trade after reverse stock split takes effect MarketWatch. Monday, March 12, 2018. 04:23 PM ET. Orexigen Bankruptcy Shows Difficulty of Marketing Weight-Loss Drugs The Wall Street Journal Interactive Edition. Monday, March 27, 2017. 08:55 AM ET 5 Reasons Why VIVUS (VVUS) Stock Should Be in Your Portfolio

Sep 11, 2018 The stock had closed Monday at 47 cents on a pre-split basis. Vivus Chief Executive John Amos had said it enacted the split because it 

VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater … VIVUS Announces 1-for-10 Reverse Stock Split | MarketScreener Stockholders approved the reverse stock split at the 2018 Annual Meeting of Stockholders on September 7, 2018, and on the same day, VIVUS’ Board of Directors approved the implementation of the reverse stock split and the ratio of 1-for-10. Shares of VIVUS common stock will trade on a post-split basis beginning on September 11, 2018. The Reason For Today’s -16.48% Weakness in VIVUS, Inc ... Mar 09, 2020 · VVUS equity has an average rating of 3, with the figure leaning towards a bullish end. 1 analysts who tracked the company were contacted by Reuters. Amongst them, 1 rated the stock as a hold while the remaining 0 were split even though not equally.

Split history for VIVUS, Inc. Stock VVUS has had 1 split. Review with ratios, actual prices and calculator for shares.

VIVUS, Inc. Common Stock (VVUS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Find the latest dividend history for VIVUS, Inc. Common Stock (VVUS) at Nasdaq. com. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. The closing price above is not necessarily indicative of 

VIVUS, Inc. - VVUS - Get Stock Split History

Sep 11, 2018 · Shares of Vivus Inc. VVUS, -1.08% rallied 6.6% to trade above the $5 mark in volatile morning trade Tuesday, after the biopharmaceutical company's 1-for-10 reverse stock split went into effect. VIVUS, Inc. Common Stock (VVUS) Stock Quotes | Nasdaq VIVUS, Inc. Common Stock (VVUS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. VVUS - VIVUS, Inc. Summary, Stock Quote and News | Benzinga

VIVUS, Inc. Common Stock (VVUS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Find the latest dividend history for VIVUS, Inc. Common Stock (VVUS) at Nasdaq. com. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. The closing price above is not necessarily indicative of  When a company such as Vertex Pharmaceuticals splits its shares, the market capitalization before and after the split takes place remains stable, meaning the